Bo Lindmark

Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography–mass spectrometry

Marita Larsson, Ulrika Logren, Martin Ahnoff et al. · Journal of Chromatography B · 2002 · 50 citations

Medicinal Chemistry, Pharmaceutical Science, Liquid Chromatography–mass Spectrometry +12

Enantioselective determination of felodipine in human plasma by chiral normal-phase liquid chromatography and electrospray ionisation mass spectrometry

Bo Lindmark, Martin Ahnoff, Bengt‐Arne Persson · Journal of Pharmaceutical and Biomedical Analysis · 2002 · 37 citations

Gas Chromatography, Medicine, Mass Spectrometry +10

Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to a Clinical Candidate Dimethylpyrazinecarboxamide Phenylcyclohexylacetic Acid (AZD7687)

Jonas G. Barlind, Udo Bauer, Alan M. Birch et al. · Journal of Medicinal Chemistry · 2012 · 36 citations · Full text

Pharmaceutical Science, Candidate Drug, Pyrazinecarboxamide Dgat1 Inhibitors +17

Accelerated drug discovery by rapid candidate drug identification

Fredrik Bergström, Bo Lindmark · Drug Discovery Today · 2019 · 33 citations

Medicinal Chemistry, Drug Target, Hit Identification +7

Inhibition of AMP Deaminase Activity Does Not Improve Glucose Control in Rodent Models of Insulin Resistance or Diabetes

Therése Admyre, Lena Amrot-Fors, Maria Andersson et al. · Chemistry & Biology · 2014 · 27 citations · Full text

Insulin Resistance, Diabetes Management, Biochemistry +12